ArticleHeliyon2024

Decreased risk of COVID-19 and long COVID in patients with psoriasis receiving IL-23 inhibitor: A cross-sectional cohort study from China.

Yifan Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.